Increased tau is usually accompanied by more clinically relevant cognitive impairment and neurodegeneration (Solé-Padullés et al., 2011; Amlien et al., 2013) especially at later stages of the AD-typical trajectory that is commonly referred to as the amyloid cascade (Jack et al., 2013). Here, MAPT is linked to Alzheimer disease.